Deutsche Bank
BDTX icon

Deutsche Bank’s Black Diamond Therapeutics BDTX Stock Holding History

Deutsche Bank’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.2K Buy
+46,038
New +$113K ﹤0.01% 3506
2025
Q2 		– Sell
-22,388
Closed -$34.7K – 3617
2025
Q1 		$34.7K Hold
22,388
– – ﹤0.01% 3432
2024
Q4 		$47.9K Hold
22,388
– – ﹤0.01% 3421
2024
Q3 		$97.4K Hold
22,388
– – ﹤0.01% 3227
2024
Q2 		$104K Buy
+22,388
New +$120K ﹤0.01% 3093
2022
Q4 		– Sell
-321,602
Closed -$544K – 4010
2022
Q3 		$544K Buy
+321,602
New +$992K ﹤0.01% 2322
2022
Q2 		– Sell
-12,363
Closed -$34K – 4134
2022
Q1 		$34K Sell
12,363
-1,462
-11% -$5.34K ﹤0.01% 3943
2021
Q4 		$74K Sell
13,825
-11,138
-45% -$77.8K ﹤0.01% 3826
2021
Q3 		$211K Sell
24,963
-91,882
-79% -$907K ﹤0.01% 3542
2021
Q2 		$1.42M Buy
116,845
+104,380
+837% +$2.06M ﹤0.01% 2538
2021
Q1 		$302K Sell
12,465
-1,095
-8% -$29.5K ﹤0.01% 3407
2020
Q4 		$435K Buy
13,560
+3,637
+37% +$119K ﹤0.01% 3000
2020
Q3 		$300K Sell
9,923
-5,747
-37% -$175K ﹤0.01% 2964
2020
Q2 		$661K Buy
15,670
+2,045
+15% +$75.3K ﹤0.01% 2481
2020
Q1 		$340K Buy
+13,625
New +$415K ﹤0.01% 2679

Other funds holding BDTX

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Deutsche Bank's BDTX Position: Q2 2026 in Review

Deutsche Bank opened a new position in Black Diamond Therapeutics (BDTX) in Q2 2026: 46,038 shares worth $85.2K. The stake represents ﹤0.01% of the portfolio and ranks #3506 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in BDTX as recently as Q1 2025.

Deutsche Bank first reported a position in BDTX in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.42M in Q2 2021. 96 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Deutsche Bank held 46,038 shares of Black Diamond Therapeutics worth $85.2K as of Q2 2026.
  • Black Diamond Therapeutics was a new Deutsche Bank position in Q2 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3506 holding.
  • Deutsche Bank first reported a position in Black Diamond Therapeutics in Q1 2020 and has held it in 15 quarters since.
  • Deutsche Bank's Black Diamond Therapeutics position peaked at $1.42M in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.